News

BioPharma Dive1h

Venture firm Frazier closes $1.3B fund for early-stage biotech investing

Frazier was among the most active venture investors in 2024, according to analysts at William Blair, backing 17 private life ...
BioPharma Dive57m

Moderna to lay of 10% of workforce in ‘difficult but necessary step’

In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...